Top Institutional Investors

Crestline Management, L.P. — 13F Holdings & Portfolio

CIK 1536054 · latest 13F-HR filed 2026-05-15

Backtest portfolio

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$46.3M

Long-equity book

Holdings

3

Distinct positions

Period

2026-03-31

Filed 2026-05-15

Q/Q Activity

+0 / −0 / ↑0 / ↓0

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • No increased positions.
Show all 0 →

Top Trims

  • No decreased positions.
Show all 0 →

New Positions

  • No new positions this quarter.
Show all 0 →

Exited Positions

  • No exits this quarter.
Show all 0 →
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 DENALI THERAPEUTICS INC DNLI 24823R105 $42.4M 91.74% 2,210,732 SH
2 SANA BIOTECHNOLOGY INC SANA 799566104 $2.2M 4.70% 755,736 SH
3 8X8 INC NEW EGHT 282914100 $1.6M 3.56% 990,850 SH
Filing History
Period Filed AUM Holdings Accession
2026-03-31 2026-05-15 $46.3M 3 0001315863-26-000422
2026-03-31 2026-05-15 $46.3M 3 0001315863-26-000412
2025-12-31 2026-02-17 $53.3M 3 0001315863-26-000165
2025-09-30 2025-11-14 $58.1M 3 0001315863-25-000800